1887

Abstract

We report that the replication-deficient DY strain of transmissible mink encephalopathy (TME) can delay disease caused by the pathogenic HY TME strain. In this study, competition between the HY and DY TME agents was investigated following superinfection of the sciatic nerve and peritoneal cavity. Initially, DY TME infection was examined in the absence of superinfection and it was found that inoculation into the brain and sciatic nerve resulted in prion disease and PrP deposition in brain but not lymphoreticular tissues. Conversely, intraperitoneal inoculation of the DY TME agent did not result in clinical symptoms, DY TME agent replication or PrP deposition 400–600 days after infection. These findings indicate that the DY TME agent does not replicate in secondary lymphoid organs and is non-pathogenic when neuroinvasion is dependent on prior infection of the lymphoreticular system. However, intraperitoneal inoculation of the DY TME agent at 60 days, but not at 30 days, prior to intraperitoneal inoculation of the HY TME agent resulted in an extension of the HY TME incubation period. Inoculation of the DY TME agent into the sciatic nerve at 60 days prior to intrasciatic nerve inoculation of the HY TME agent did not delay the incubation period of HY TME. The ability of the DY TME agent to delay HY TME infection following extraneural inoculation, but not neural infection, suggests that HY and DY TME agent competition can occur in a common replication site whose cellular location precedes infection of both the lymphoreticular and peripheral nervous systems.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.19394-0
2004-01-01
2024-11-05
Loading full text...

Full text loading...

/deliver/fulltext/jgv/85/1/vir850265.html?itemId=/content/journal/jgv/10.1099/vir.0.19394-0&mimeType=html&fmt=ahah

References

  1. Bartz J. C., Bessen R. A., McKenzie D., Marsh R. F., Aiken J. M. 2000; Adaptation and selection of prion protein strain conformations following interspecies transmission of transmissible mink encephalopathy. J Virol 74:5542–5547
    [Google Scholar]
  2. Bartz J. C., Kincaid A. E., Bessen R. A. 2002; Retrograde transport of transmissible mink encephalopathy within descending motor tracts. J Virol 76:5759–5768
    [Google Scholar]
  3. Bessen R. A., Marsh R. F. 1992a; Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent. J Virol 66:2096–2101
    [Google Scholar]
  4. Bessen R. A., Marsh R. F. 1992b; Identification of two biologically distinct strains of transmissible mink encephalopathy in hamsters. J Gen Virol 73:329–334
    [Google Scholar]
  5. Bessen R. A., Marsh R. F. 1994; Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J Virol 68:7859–7868
    [Google Scholar]
  6. Bruce M. E. 1985; Agent replication dynamics in a long incubation period model of mouse scrapie. J Gen Virol 66:2517–2522
    [Google Scholar]
  7. Collis S. C., Kimberlin R. H. 1985; Long-term persistence of scrapie infection in mouse spleens in the absence of clinical disease. FEMS Microbiology Lett 29:111–114
    [Google Scholar]
  8. Dickinson A. G., Fraser H. 1979; The scrapie replication-site hypothesis and its implications for pathogenesis. In Slow Transmissible Diseases of the Nervous System pp  12–31 Edited by Prusiner S. B., Hadlow W. J. New York: Academic Press;
    [Google Scholar]
  9. Dickinson A. G., Fraser H., Meikle V. M., Outram G. W. 1972; Competition between different scrapie agents in mice. Nat New Biol 237:244–245
    [Google Scholar]
  10. Dickinson A. G., Fraser H., McConnell I., Outram G. W., Sales D. I., Taylor D. M. 1975; Extraneural competition between different scrapie agents leading to loss of infectivity. Nature 253:556
    [Google Scholar]
  11. Garfin D. E., Stites D. P., Perlman J. D., Cochran S. P., Prusiner S. B. 1978; Mitogen stimulation of splenocytes from mice infected with scrapie agent. J Infect Dis 138:396–400
    [Google Scholar]
  12. Kascsak R. J., Rubenstein R., Merz P. A., Tonna-DeMasi M., Fersko R., Carp R. I., Wisniewski H. M., Diringer H. 1987; Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J Virol 61:3688–3693
    [Google Scholar]
  13. Kasper K. C., Stites D. P., Bowman K. A., Panitch H., Prusiner S. B. 1982; Immunological studies of scrapie infection. J Neuroimmunol 3:187–201
    [Google Scholar]
  14. Kimberlin R. H., Walker C. 1977; Characteristics of a short incubation model of scrapie in the golden hamster. J Gen Virol 34:295–304
    [Google Scholar]
  15. Kimberlin R. H., Walker C. A. 1985; Competition between strains of scrapie depends on the blocking agent being infectious. Intervirology 23:74–81
    [Google Scholar]
  16. Kimberlin R. H., Walker C. A. 1986; Pathogenesis of scrapie (strain 263K) in hamsters infected intracerebrally, intraperitoneally or intraocularly. J Gen Virol 67:255–263
    [Google Scholar]
  17. Kingsbury D. T., Smeltzer D. A., Gibbs C. J. Jr, Gajdusek D. C. 1981; Evidence for normal cell-mediated immunity in scrapie-infected mice. Infect Immun 32:1176–1180
    [Google Scholar]
  18. McBride P. A., Schulz-Schaeffer W. J., Donaldson M., Bruce M., Diringer H., Kretzschmar H. A., Beekes M. 2001; Early spread of scrapie from the gastrointestinal tract to the central nervous system involves autonomic fibers of the splanchnic and vagus nerves. J Virol 75:9320–9327
    [Google Scholar]
  19. Manuelidis L. 1998; Vaccination with an attenuated Creutzfeldt–Jakob disease strain prevents expression of a virulent agent. Proc Natl Acad Sci U S A 95:2520–2525
    [Google Scholar]
  20. Manuelidis L., Yun Lu Z. 2000; Attenuated Creutzfeldt–Jakob disease agents can hide more virulent infections. Neurosci Lett 293:163–166
    [Google Scholar]
  21. National Research Council 1996 Guide for the Care and Use of Laboratory Animals Washington, DC: National Academy Press;
    [Google Scholar]
  22. Porter D. D., Porter H. G., Cox N. A. 1973; Failure to demonstrate a humoral immune response to scrapie infection in mice. J Immunol 111:1407–1410
    [Google Scholar]
  23. Prinz M., Montrasio F., Klein M. A., Schwarz P., Priller J., Odermatt B., Pfeffer K., Aguzzi A. 2002; Lymph nodal prion replication and neuroinvasion in mice devoid of follicular dendritic cells. Proc Natl Acad Sci U S A 99:919–924
    [Google Scholar]
  24. Prusiner S. B. 1991; Molecular biology of prion diseases. Science 252:1515–1522
    [Google Scholar]
  25. Schulz-Schaeffer W. J., Fatzer R., Vandevelde M., Kretzschmar H. A. 2000; Detection of PrP(Sc) in subclinical BSE with the paraffin-embedded tissue (PET) blot. Arch Virol Suppl 16:173–180
    [Google Scholar]
  26. Somerville R. A., Birkett C. R., Farquhar C. F. 8 other authors 1997; Immunodetection of PrPSc in spleens of some scrapie-infected sheep but not BSE-infected cows. J Gen Virol 78:2389–2396
    [Google Scholar]
  27. Spongiform Encephalopathy Advisory Council. 2001 Statement on Infectivity in Bovine Tonsil London: DEFRA, DH, FSA:
    [Google Scholar]
  28. Terry L. A., Marsh S., Ryder S. J., Hawkins S. A., Wells G. A., Spencer Y. I. 2003; Detection of disease-specific PrP in the distal ileum of cattle exposed orally to the agent of bovine spongiform encephalopathy. Vet Rec 152:387–392
    [Google Scholar]
  29. Wells G. A., Hawkins S. A., Green R. B., Austin A. R., Dexter I., Spencer Y. I., Chaplin M. J., Stack M. J., Dawson M. 1998; Preliminary observations on the pathogenesis of experimental bovine spongiform encephalopathy (BSE): an update. Vet Rec 142:103–106
    [Google Scholar]
/content/journal/jgv/10.1099/vir.0.19394-0
Loading
/content/journal/jgv/10.1099/vir.0.19394-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error